Sunday, May 16, 2021 |
Light Rain

Rockville immunotherapy company Sensei Biotherapeutics executes $133M IPO

February 9, 2021

Maryland biotech Sensei Biotherapeutics Inc. has officially moved to the public arena. The Rockville immunotherapy company, which develops cancer therapeutics, made its debut on the Nasdaq Global Market Feb. 4 poised to secure $133 million in proceeds from the offering. That’s after increasing its inaugural share price to $19 for more than 7 million shares of common stock. The IPO was scheduled to close Monday, subject to satisfying customary closing conditions.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.